In the call they stated they had an acquisition that fell through.Pulling down so much of the funding in advance that it damaged the result is also curious, unless it was supposed to have been used to fund an acquisition?
Changing the name of the company was a great idea, what they changed it to is not so great.
- Forums
- ASX - By Stock
- Ann: Solvar 1H FY23 Results
SVR
solvar limited
Add to My Watchlist
1.22%
!
$1.67

Pulling down so much of the funding in advance that it damaged...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.67 |
Change
0.020(1.22%) |
Mkt cap ! $328.0M |
Open | High | Low | Value | Volume |
$1.67 | $1.69 | $1.63 | $504.3K | 304.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3210 | $1.62 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.68 | 386 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3210 | 1.615 |
1 | 328 | 1.585 |
1 | 788 | 1.580 |
2 | 18500 | 1.570 |
3 | 11643 | 1.550 |
Price($) | Vol. | No. |
---|---|---|
1.680 | 386 | 1 |
1.685 | 2100 | 2 |
1.690 | 108336 | 2 |
1.700 | 9918 | 1 |
1.790 | 5606 | 1 |
Last trade - 16.11pm 26/06/2025 (20 minute delay) ? |
Featured News
SVR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online